Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Manisha Pandey

11PUBLICATIONS
39CO-AUTHORS
AutoimmunityInnate immunityMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Feb 25, 2025
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease.

Rukshan Ahamed Mohamed Rafeek, Natkunam Ketheesan, Michael F Good

|Dec 03, 2024
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.

Joshua Osowicki, Hannah R Frost, Kristy I Azzopardi

|Sep 25, 2023
A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils.

Victoria Ozberk, Mehfuz Zaman, Ailin Lepletier

|Jul 14, 2023
Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus.

Shuxiong Chen, Victoria Ozberk, Gayathri Sam

|Feb 06, 2023
Streptolysin O Deficiency in Streptococcus pyogenes M1T1 <i>covR/S</i> Mutant Strain Attenuates Virulence in <i>In Vitro</i> and <i>In Vivo</i> Infection Models.

Emma L Langshaw, Simone Reynolds, Victoria Ozberk

|Feb 04, 2023
Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model.

Simone Reynolds, Rukshan Ahamed Mohamed Rafeek, Adam Hamlin

Pageof 2

Frequent Collaborators

7 joint publications

Michael F Good

4 joint publications

Ailin Lepletier

4 joint publications

Ainslie Calcutt

2 joint publications

Senthil Murugappan

2 joint publications

Jamie-Lee Mills

2 joint publications

S Ben Baker

2 joint publications

Mariusz Skwarczynski

2 joint publications

Rukshan Ahamed Mohamed Rafeek

2 joint publications

Angus H Forster

2 joint publications

Istvan Toth

Frequent Collaborators

7 joint publications

Michael F Good

4 joint publications

Ailin Lepletier

4 joint publications

Ainslie Calcutt

2 joint publications

Senthil Murugappan

Top Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on : May 08, 2020

7.6K
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on : Apr 05, 2019

12.1K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

2.6K
See more related videos

Top Related Videos

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
09:25

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

Published on : May 08, 2020

7.6K
Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on : Apr 05, 2019

12.1K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

2.6K
See more related videos